VITRUVIAN PARTNERS


Associated tags: Vitruvian Partners, Data Management, Professional Services, Health, OAG, Partner, Airline, Family, Air travel, Travel, Ecosystem, Pleasure, Customer, Software, Transport, Air, Workflow, Biotechnology, Patient, Finance

ObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners

Retrieved on: 
Friday, January 26, 2024

ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm.

Key Points: 
  • ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm.
  • ObjectiveHealth is an innovator in clinical research, seamlessly integrating clinical trials into the practices of physicians, while deploying proprietary advanced technology to identify and recruit patients for the trials.
  • Vitruvian’s investment will provide the capacity for ObjectiveHealth to expand its operations and continue its rapid pace of growth.
  • “Under Colleen and Don’s leadership, ObjectiveHealth has built an innovative and disruptive platform for advancing clinical research,” said Sophie Bower-Straziota, partner at Vitruvian.

OAG Acquires Infare and Receives New Investment from Vitruvian Partners

Retrieved on: 
Friday, July 28, 2023

Together, OAG and Infare have an exciting journey ahead to leverage a truly market-leading end-to-end data platform to serve mission-critical air travel intelligence needs across the world.

Key Points: 
  • Together, OAG and Infare have an exciting journey ahead to leverage a truly market-leading end-to-end data platform to serve mission-critical air travel intelligence needs across the world.
  • Together, there is a significant opportunity for OAG and Infare to better serve airline partners and the wider travel ecosystem with high-quality data and innovative solutions.
  • Infare is the partner of choice for airlines demanding the highest quality competitor air travel data source to support their growth.
  • I am excited to welcome Infare colleagues to the OAG family.”
    “Access to comprehensive and accurate data is paramount for making informed business decisions.

OAG Acquires Infare and Receives New Investment from Vitruvian Partners

Retrieved on: 
Friday, July 28, 2023

Together, OAG and Infare have an exciting journey ahead to leverage a truly market-leading end-to-end data platform to serve mission-critical air travel intelligence needs across the world.

Key Points: 
  • Together, OAG and Infare have an exciting journey ahead to leverage a truly market-leading end-to-end data platform to serve mission-critical air travel intelligence needs across the world.
  • Together, there is a significant opportunity for OAG and Infare to better serve airline partners and the wider travel ecosystem with high-quality data and innovative solutions.
  • Infare is the partner of choice for airlines demanding the highest quality competitor air travel data source to support their growth.
  • I am excited to welcome Infare colleagues to the OAG family.”
    “Access to comprehensive and accurate data is paramount for making informed business decisions.

DentalMonitoring, the Leading AI-Based Dental Software Company, Announces a $150 Million Growth Financing, Reaching a Valuation Over $1 Billion

Retrieved on: 
Thursday, October 21, 2021

DentalMonitoring has become the first dental software company to attain a valuation over $1 billion announcing a $150 million growth financing.

Key Points: 
  • DentalMonitoring has become the first dental software company to attain a valuation over $1 billion announcing a $150 million growth financing.
  • To date, there are over one million patients in more than 50 countries that have taken more than a billion intraoral images on the DentalMonitoring platform.
  • We will continue to deliver even more innovative solutions for dental professionals to help them provide better care and scale their practices.
  • Vitruvian is a leading international growth investor headquartered in London with offices in London, Stockholm, Munich, Luxembourg, San Francisco and Shanghai.

Ark Closes $3.4M in Series A Financing Led by Vitruvian Partners

Retrieved on: 
Wednesday, April 7, 2021

Ark, a cloud-based, highly configurable investor portal designed for private equity, venture capital and real estate fund managers and fund administration firms, today announced it closed $3.4 million in Series A financing led by Vitruvian Partners.

Key Points: 
  • Ark, a cloud-based, highly configurable investor portal designed for private equity, venture capital and real estate fund managers and fund administration firms, today announced it closed $3.4 million in Series A financing led by Vitruvian Partners.
  • Ark already supports more than 10,000 limited partners and $75 billion in capital commitments while in the early stages of the company's growth, said Joseph OMara, partner at Vitruvian Partners.
  • Im honored and excited to join the team at Ark, especially at such a momentous time for the company, Stype said.
  • Both Rob and Vitruvian Partners bring deep experience to Ark and will allow us to further extend the industrys most dynamic, scalable, and cost-effective investor portal, said Bill Ward, COO of Ark.

Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

Retrieved on: 
Tuesday, July 17, 2018

As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials.

Key Points: 
  • As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials.
  • CRF Health has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.
  • "CRF's technology and therapeutic experience dovetail well with our solutions, and they expand our ability to support increasingly complex clinical research.
  • The 2.4bn Vitruvian Investment Partnership III ("VIP III") is among the largest pools of capital in Europe supporting innovative and higher growth companies.